HONG KONG, Aug 14 (Reuters) – A unit of Chinese conglomerate
Fosun Group’s pharmaceutical business on Monday said it is
bidding for a stake in U.S. speciality drugmaker Arbor
Pharmaceuticals LLC.

Read More At Article Source | Article Attribution